Бегущая строка

BUOU.SI $1.27 -0.7812%
HSCSW $0.15 -25.6122%
ANGHW $0.07 11.2957%
ROAD $28.51 0.3873%
0R2H.L $160.92 0.5813%
TAYN.PA $1.21 0%
SCF.L $308.00 1.1494%
BYFC $0.92 -2.6349%
CTIB $1.83 -0.5435%
HNST $2.02 -4.5024%
0662.HK $3.40 0%
IRD.PA $44.20 0%
NGACU $9.26 0%
CHPMW $0.00 0%
LBRDP $22.05 0.1367%
GNPX $0.82 0.984%
USIO $2.06 1.9802%
HUT $1.71 1.7857%
8275.HK $0.75 11.9403%
TRAQ $10.50 0%
0R1T.L $89.25 -2.1634%
PX $10.12 0%
0R8T.L $36.22 0%
SDEM $23.32 -1.1265%
FGLS.L $5.66 0.6495%
BCML $15.05 -1.3115%
1841.HK $0.38 0%
8239.HK $0.45 0%
CWFU.L $236.75 -2.81199%
MFM $5.10 0%
0H68.L $65.61 -1.0483%
0508.HK $0.04 5.5556%
SOI.PA $127.10 -4.6869%
TTEK $145.07 -1.3331%
RIV.L $49.40 0%
BOTG.L $13.28 0.0905%
DIVO $35.21 -0.1984%
INGR $108.74 -0.8118%
IDKO.L $41.12 -0.7393%
HCAQ $10.92 0%
SDEF $17.42 0%
ARBE $2.09 -2.7907%
ALPRO.PA $8.95 0.5618%
ERNA.L $5.46 0.0366%
JCICW $0.22 0%
DOO $43.44 0%
NMFC $11.93 -0.0419%
PBFS $8.10 -0.6135%
BN4.SI $6.40 -0.4666%
2280.HK $0.38 4.1096%
ESQ $40.05 1.7143%
2230.HK $0.18 -0.5464%
HAS.L $112.80 0.3559%
AFAC $10.27 0%
NLSP $1.15 -5.7377%
CCAC-UN $7.66 0%
GOL $2.91 -2.8428%
ROSC $34.01 -0.548%
BRLIX $9.81 0%
NFG $51.50 -0.4254%
1859.HK $0.08 0%
IBDV $21.41 -0.3723%
GBUG $29.60 0%
ARW $117.74 -0.8088%
GIPR $4.34 0.7905%
GAL.L $19.00 -0.5236%
CI $255.49 -1.7346%
WEBR $8.12 0%
CCXI $51.99 0%
SAA $18.75 -1.2586%
GILI.L $14 498.00 -1.1421%
NOVVU $10.39 0%
ZEUS $41.30 -2.5484%
YDUQ3.SA $12.29 -0.1625%
USEA $2.76 -2.1312%
AFACW $0.00 0%
ATMR $10.53 0%
RCACW $0.11 39.3258%
HHH $12.39 0%
SLB $43.99 -0.3398%
GBP5.L $928.65 -0.0431%
0OC9.L $42.00 -9.9967%
MMLG $19.17 -0.9369%
1765.HK $0.61 -4.6875%
ONVO $1.80 -1.6393%
ARCK $11.90 0%
EOCW $10.29 -0.0039%
TTG.L $169.60 -0.2353%
PSB-PY $11.95 -5.23394%
WB $15.93 -0.5618%
UTHR $212.72 -0.356%
0527.HK $0.05 0%
EOG.L $1.07 2.2857%
XAXD.L $43.50 -0.6056%
IJJ $97.95 -0.8067%
MMLP $2.27 -5.6083%
ASB-PE $15.02 -1.5714%
IJUL $25.95 -0.1512%
PAY $9.11 -0.9783%
NSTC-UN $10.15 0.3956%

Хлебные крошки

Акции внутренные

Лого

Zogenix, Inc. ZGNX

$26.68

На 18:00, 12 мая 2023

-2.55%

Потенциал через год

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    0.00000000

  • week52high

    26.90

  • week52low

    11.03

  • Revenue

    81690000

  • P/E TTM

    -6

  • Beta

    0.89911400

  • EPS

    -4.07000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    28 февр 2022 г. в 05:00

Описание компании

Zogenix, Inc., a biopharmaceutical company, develops and commercializes therapies to transform the lives of patients and their families living with rare diseases in the United States. The company's lead product candidate is the Fintepla, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome, as well as to treat seizures associated with Lennox-Gastaut syndrome; and that is in Phase II clinical trials for the treatment of other rare epileptic syndromes and diseases. It is also developing MT1621, an investigational therapy for the treatment of a rare genetic disorder called thymidine kinase 2 deficiency. Zogenix, Inc. has a collaboration with Tevard Biosciences for the research, development and commercialization of novel gene therapies for Dravet Syndrome and other genetic epilepsies. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was incorporated in 2006 and is headquartered in Emeryville, California.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.

Рекомендации аналитиков

Grading company New grade Previous grade Recommendation date
Needham Hold Buy 19 янв 2022 г.
SVB Leerink Outperform Outperform 20 дек 2021 г.
UBS Buy 09 сент 2021 г.
SVB Leerink Outperform Outperform 06 авг 2021 г.
Needham Buy Buy 06 авг 2021 г.

Свежие комментарии

Свежие комментарии

Оставьте свой голос

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%
  • Нет

    12%

Проголосовал 8 человек

Insider Summary

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
MAST ERLE T D 0 22000 07 мар 2022 г.
MAST ERLE T D 0 3027 07 мар 2022 г.
Farfel Gail M D 0 40187 07 мар 2022 г.
Farfel Gail M D 0 40187 07 мар 2022 г.
Farfel Gail M D 0 16606 07 мар 2022 г.
Galer Bradley S. D 0 45499 07 мар 2022 г.
Galer Bradley S. D 0 45499 07 мар 2022 г.
Galer Bradley S. D 0 25022 07 мар 2022 г.
Mitchell Shawnte D 0 25000 07 мар 2022 г.
Mitchell Shawnte D 0 25000 07 мар 2022 г.